Improving cancer communication to patients
Oncologists and their patients are increasingly challenged with making difficult decisions about screening, prevention and treatment. Unfortunately, most patients are neither armed with adequate knowledge nor the means of interpreting the information they do have in a qualitatively and quantitatively useful way.
In a commentary published Sept. 19 in the Journal of the National Cancer Institute, Angela Fagerlin, Ph.D., of the Center for Bioethics and Social Sciences in Medicine at the University of Michigan and the VA Ann Arbor Center for Clinical Management Research, and colleagues highlight 10 recommendations for improved communication to patients.
These methods have been shown to improve patients' understanding of the information they are presented with when asked to make important decisions.
The authors first outline typical problems that arise when physicians must present complex medical information to patients and break it down in simple terms. Patients often don't have the health literacy needed to understand what their doctors say to them and have difficulty grasping the reading materials they obtain through the health providers. Patients also tend to lack the numeracy skills needed to comprehend useful statistics such as risk and benefit statistics.
The researchers recommend that doctors use plain language to make their written and verbal materials more understandable and present only information that is relevant to patients. They also say the order of presenting types of information is important: citing the "recency effect," which shows that patients better remember the most recent information presented to them.
Presenting information in terms of absolute risks (the specific chances of developing the disease under different circumstances) rather than relative risks (e.g., "50% greater risk") is another strategy the researchers recommend.
Research has shown that when relative risk is used, risk reduction appears larger and treatments are viewed more favorably, which can inappropriately lead patients and physicians to choose treatments, they write. The authors also urge doctors to always emphasize the element of time, because patients may make different decisions based on the time period presented. For example, presenting a patient's lifetime risk (e.g., instead of the risk within a ten-year interval) can lead to different perception of the risk in a patient's mind.
In their summary, the authors point out that their commentary is not a systematic review of the literature but focuses on some of the most commonly accepted recommendations for risk communication. They write, "We believe it is the responsibility of all cancer educators, decision aid developers, and clinicians to be familiar with the growing body of rigorous research that has tested effective methods of presenting probabilistic information, so that patients can use it to make an informed decision."
Provided by Journal of the National Cancer Institute
- Putting risk in perspective: Do people make better decisions when they understand average risk? Dec 13, 2007 | not rated yet | 0
- Confusing risk information may lead breast cancer patients to make poor treatment choices Dec 08, 2008 | not rated yet | 0
- Just a numbers game? Making sense of health statistics Oct 10, 2008 | not rated yet | 0
- Poorly presented risk statistics could misinform health decisions Mar 16, 2011 | not rated yet | 0
- Too Much Information? Risk-benefit data does not always lead to informed decision-making Apr 14, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
How can there be a term called "intestinal metaplasia" of stomach
8 hours ago Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
- More from Physics Forums - Medical Sciences
More news stories
An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.
Cancer 1 hour ago | not rated yet | 0
The surgical management of non-small cell lung cancer (NSCLC) in U.S. hospitals varies widely depending on the race of the patient, according to a new study.
Cancer 5 hours ago | not rated yet | 0
Treatment with an Alpha-1 proteinase inhibitor (A1-PI), a naturally occurring protein that protects lung tissue from breakdown and protects the lung's elasticity, is effective in slowing the progression of emphysema in patients ...
Cancer 5 hours ago | not rated yet | 0
Scientists from Nanyang Technological University (NTU) and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells.
Cancer 5 hours ago | 5 / 5 (1) | 0
Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.
40 minutes ago | not rated yet | 0 |
The decision to limit life support in patients in the intensive care unit (ICU) appears to be significantly influenced by physician practices and/or the culture of the hospital, suggests new findings from researchers at the ...
58 minutes ago | not rated yet | 0
Children with obstructive sleep apnea who had a common surgery to remove their tonsils and adenoids showed notable improvements in behavior, quality of life and other symptoms compared to those treated with "watchful waiting" ...
58 minutes ago | not rated yet | 0
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
3 hours ago | 4 / 5 (3) | 0 |
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
1 hour ago | 4.7 / 5 (3) | 0 |
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
3 hours ago | 4.5 / 5 (2) | 0 |